- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Plasma Copeptin Levels may predict Arterial Disorder in Type 2 Diabetes Patients: Study
Sweden: A recent cross-sectional study has shed light on the correlation between plasma copeptin levels and markers of arterial disorder in individuals with type 2 diabetes (T2D). Conducted by a team of researchers, the study underscores the importance of monitoring copeptin levels as a potential biomarker for assessing cardiovascular risk in diabetic patients.
The CARDIPP study, published in Cardiovascular Diabetology, revealed that plasma copeptin may be a helpful surrogate for identifying individuals at higher risk for arterial disorders.
"Findings revealed that higher copeptin levels were linked to lower toe brachial index (TBI) and increased aortic pulse wave velocity in 519 patients aged 55–65," the researchers reported. "These associations remained robust regardless of key risk factors such as sex, age, diabetes duration, and HbA1c levels."
Arterial stiffness, characterized by reduced arterial compliance, is a hallmark of vascular aging and is closely linked to the development of cardiovascular events in diabetic individuals. Endothelial dysfunction, on the other hand, refers to impaired endothelial function, which plays a pivotal role in the initiation and progression of atherosclerosis.
Currently, there is a limited understanding of the relationship between copeptin, the mid-regional portion of proadrenomedullin (MRproADM) and the midregional fragment of the N-terminal of proatrial natriuretic peptide (MRproANP), and arterial disorders. Aortic pulse wave velocity (aPWV) and toe brachial index (TBI) are established parameters for detecting arterial disorders.
Against the above background, Lee Ti Davidson, Linköping University, Linköping, Sweden, and colleagues evaluated whether copeptin, MRproADM, and MRproANP were associated with TBI and aPWV in T2D patients with no history of cardiovascular disease (CVD).
For this purpose, the researchers conducted a cross-sectional analysis of 519 type 2 diabetes patients aged 55–65 years with no history of CVD at baseline, had complete data on copeptin, MRproANP, MRproADM, aPWV, and TBI was performed. The associations between conventional CVD risk factors, copeptin, MRproADM, MRproANP, TBI, and aPWV, were investigated using Linear regression analysis.
The study led to the following findings:
· Copeptin was associated with TBI (β–0.0020) and aPWV (β 0.023).
· These associations were independent of age, sex, diabetes duration, mean 24-hour ambulatory systolic blood pressure, glycated hemoglobin A1c, estimated glomerular filtration rate, total cholesterol, body mass index, and active smoking.
Copeptin, a biomarker of various stresses, is associated with TBI, and aPWV, a marker of arterial disorders, independently of age, sex, diabetes duration, smoking status, BMI, HbA1c, eGFR, total cholesterol, and mean 24-hour ambulatory SBP. Measuring copeptin levels may make identifying individuals at risk for arterial disorders simpler than current methods, such as TBI or aPWV.
"There is a need to conduct further studies to evaluate the predictive value of copeptin levels in identifying patients at increased risk of arterial disorders in primary care," the researchers concluded.
Reference:
Davidson, L.T., Engvall, J., Chisalita, S.I. et al. Plasma copeptin and markers of arterial disorder in patients with type 2 diabetes, a cross-sectional study. Cardiovasc Diabetol 23, 200 (2024). https://doi.org/10.1186/s12933-024-02291-2
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751